Refine by
Sars Cov 2 Articles & Analysis
85 articles found
The success of mRNA vaccines against viruses like SARS-CoV-2 has propelled this technology into the spotlight, showcasing its speed and efficacy in addressing public health challenges. ...
Precision-Cut Lung Slices (PCLS) have emerged as a innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses. By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in vitro cell cultures and the ...
Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact individual wellbeing and healthcare costs, resource ...
Goal Understanding of Coronavirus (SARS-CoV-2) of interest using whole-genome sequence data from NCBI Solution Loci helps the scientists to understand the Coronavirus at the molecular level with a few click ...
From a vaccine perspective, the V3 loop of the gp120 envelope protein of HIV-1 (HIV envelope variable region 3, V3) has been identified as a candidate for peptide-based vaccine design as it is a target for neutralizing antibodies.SARS-CoV-2 and Related CoronavirusesThe global COVID-19 pandemic caused by the ...
These disease models, such as the SARS-CoV-2 mouse model, have proven invaluable in understanding disease transmission, immune response, and the effect of intervention strategies. ...
SARS-CoV-2 can enter host cells by binding to receptors like the angiotensin-converting enzyme 2 (ACE2). ...
Cancer, Alzheimer's disease, and Parkinson's disease are just a few of the illnesses for which EVs can be used as biomarkers. Viruses: Viruses like HIV and SARS-CoV-2 can be detected and quantified using nano-flow cytometry. ...
SARS-CoV-2 is a newly discovered human coronavirus group (HCoV), which are single-stranded RNA viruses belonging to the family of Coronaviridae. ...
While the RT-qPCR assay was a gold-standard means of finding respiratory infectious viruses such as SARS-CoV and MERS-CoV 12-15, there are some restrictions to existing RT-qPCR assays targeting SARS-CoV-2. ...
These disease models, such as the SARS-CoV-2 mouse model, have proven invaluable in understanding disease transmission, immune response, and the effect of intervention strategies. ...
Mechanism of Action of Trofinetide Most cases of Rett syndrome are associated with loss-of-function mutations in the gene encoding methyl CpG-binding protein 2 (MECP2). MECP2 is a DNA-binding protein that plays a role in the epigenetic regulation of gene expression. ...
Results suggest that purified clinoptilolite in a liquid or gel suspension may represent a natural, safe, and effective candidate for the development of a medical device destined to reduce SARS-CoV-2 infectivity and virus spread in patients. Read the full ...
Understanding the functional characteristics and cellular tropism of SARS-CoV-2, as well as the pathogenesis leading to multi-organ failure and death, has driven the unprecedented adoption of organoid models. ...
Addressing the Origin of the Virus While the geographic origin of the virus is well-known, the debate continues as to whether the origin of the SARS-CoV-2 coronavirus outbreak was the result of natural transmission or a negligent lab leak, which we are seeing more evidence arise. ...
uenza, Vaccinia, Ross River, West Nile, Chikungunya, Tick-borne encephalitis virus (TBE), Hepatitis A, and SARS-Coronavirus including SARS CoV-2. ...
ByNuvonis
Early in January 2020, sequencing revealed a novel coronavirus (now termed SARS-CoV-2) as the causal factor for the disease designated as COVID-19. ...
ByNuvonis
In addition, viral vectors based on Newcastle disease virus have been previously evaluated as vaccines against e.g. Sars-CoV-2, Ebola, H5N1 influenza, West Nile, and Simian Immunodeficiency virus. ...
ByNuvonis
UK-based hVIVO Services Limited produced two different viral strains of SARS-CoV-2 in Nuvonis’ Vero cells under GMP conditions, a Wuhan-like D614G virus and a Delta strain. ...
ByNuvonis
Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began in 2019 and rapidly scaled to a global presence of disease known as COVID-19. ...